ACOR

Acorda Therapeutics

Delisted

ACOR was delisted on the 11th of April, 2024.

175 hedge funds and large institutions have $1.42B invested in Acorda Therapeutics in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 53 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
175
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$18.7M
Puts
$28.5M
Net Calls
Net Calls Change

Top Buyers

1 +$30.5M
2 +$13.6M
3 +$12.9M
4
BlackRock
BlackRock
New York
+$11.6M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.62M

Top Sellers

1 -$34.3M
2 -$31.1M
3 -$24.1M
4
State Street
State Street
Massachusetts
-$18.3M
5
HM
HealthCor Management
New York
-$18.2M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$219M
2
$197M
3
$178M
4
$139M
5
$85.1M
6
$62M
7
$53.5M
8
$37.6M
9
$30.1M
10
$27M
11
$22.4M
12
$19.5M
13
$19.4M
14
$18.7M
15
$16.2M
16
$15.2M
17
$14.4M
18
$11.8M
19
$10.7M
20
$10.6M
21
$9.74M
22
$9.5M
23
$9.42M
24
$9.4M
25
$8.99M